Propharma Group India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -5.33%
- Profit Growth -29.49%
- Ebitda -22.26%
- Net Worth 55.19%
- Total Assets 45.29%
About Propharma Group India
Propharma Group India Private Limited (PGIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 December 2008 and has a history of 16 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Isafety Systems Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jason Degoes and Srinivasa Hemadri serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72200TG2008PTC062114
-
Company No.
062114
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Dec 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Propharma Group India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jason Degoes
|
Director | 07-Aug-2021 | Current |
Srinivasa Hemadri
|
Director | 15-May-2023 | Current |
Financial Performance of Propharma Group India.
Propharma Group India Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.33% decrease. The company also saw a substantial fall in profitability, with a 29.49% decrease in profit. The company's net worth Soared by an impressive increase of 55.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Propharma Group India?
In 2022, Propharma Group India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Propharma Group India?
Propharma Group India has a workforce of 113 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Propharma Group India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Propharma Group India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
